Spring 2025

Volume 17, Number 1

Syndemics and HIV

Features

Featured Article

Syndemics and HIV: Unraveling the Complex Web of Health Inequities

Since the earliest days of the HIV/AIDS pandemic, marginalized populations, and most especially racial and ethnic minority groups, have been…

Syndemic Thinking and the Future of Health Care Design

Syndemic Thinking and the Future of Health Care Design

Optimizing Synergies to Enhance Care for Poor and Underserved Communities

On January 29, 2025, Secretary of State Marco Rubio approved an “Emergency Humanitarian Waiver” to allow the President’s Emergency Plan…

The Syndemic of HIV and Substance Use in Adolescence

The Syndemic of HIV and Substance Use in Adolescence

Origins of HIV/AIDS Syndemic Theory Syndemics arise when two or more clusters of epidemics occur within a population as a…

Fueling the Fire

Fueling the Fire

The Impact of Methamphetamines on HIV Transmission and Care

“It’s the government’s way of controlling people,” remarked one patient with HIV when asked about his interest in restarting antiretroviral…

Mental Health HIV and Managing Multiple Medications

Mental Health, HIV, and Managing Multiple Medications

Introduction As the general population of people with HIV continues to age, so accompanies the risk for polypharmacy (the use…

Addressing Mental Health and Substance Use in HIV care

Addressing Mental Health and Substance Use in HIV Care

A Therapist’s Perspective

In my work as a therapist, I witness daily how my patients’ HIV diagnosis and trauma can intersect and compound…

Sections

LFTD Bruce Packet

The Interconnectedness of Disease

American Academy of HIV Medicine Statement on Recent White House Executive Orders

The American Academy of HIV Medicine Announces Second Year for Fellowship to Improve HIV Prevention and PrEP Access

As Prevention Strategy for Sexually Transmitted Infections Rolls Out, Experts Highlight both Promise and Knowledge Gaps

Doxycycline has Population-Level Benefits, Warrants Vigilance for Antimicrobial Resistance

First Clinical Data for Gilead’s Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet

Advancing HIV Awareness and Access

The Dr. Dawn K. Smith HIV Prevention Clinical Fellowship

Clinical Research Update – Spring 2025

Scroll to Top

Search